Upload Avatar (500 x 500)
Jing Chen
jingchen@bjmu.edu.cn
Chinese, English
Beijing
Peking University
Pharmaceutical Sciences
  • Ph.D. in Science: Peking University
  • M.Sc. in Science: China Pharmaceutical University
  • B.Sc. in Science: China Pharmaceutical University
  • 2003.08-Present - Peking University School of Pharmaceutical Sciences, Department of Pharmacy Administration and Clinical Pharmacy - Lecturer, Associate Researcher
  • 2019.09-2020.08 - University of Southern California - Visiting Scholar
  • 2003.08-Present - International Research Center for Pharmaceutical Management, Peking University - Researcher
  • Xue Muqiao Price Research Award (2018)
  • Excellent Paper Award at the Annual Conference of the Chinese Pharmaceutical Association (2018)
  • Outstanding Teaching Award, Peking University Health Science Center (2017)
  • Outstanding Teaching Award, Peking University Health Science Center (2011)
  • Outstanding Teacher, Peking University Health Science Center (2008)
Pharmaceutical Policy and Law
  • Analysis of 240 Cases of Medication Errors Leading to Medical Liability Disputes, Hu Lin, Gu Jiahui, Du Haoxin, Bao Qi, Yu Aichen, Li Hao, Fan Pingan, Nie Xiaoyan, Shi Luwen, Jing Chen, 2021
  • Analysis of the Impact of Patent Expiry on Drug Prices and Market Share, Bai Lin, Zhang Yichen, Fan Pingan, Shi Luwen, Jing Chen, 2021
  • Trends in New Drug Development and Approval from 1985 to 2019 in the United States, Bai Lin, Fan Pingan, Shi Luwen, Jing Chen, 2021
  • Analysis of the Use of the 7th Edition of the WHO Model List of Essential Medicines for Children in Children's Hospitals, Han Taisen, Wang Ruilin, Jing Chen, Shi Luwen, 2021
  • Analysis of Generic Drug Policies in China, Jing Chen, Fan Pingan, Han Sheng, Lin Fanghui, Shi Luwen, 2021
  • Analysis of the Qualification and Approval of Orphan Drugs in the United States, Wang Min, Fan Pingan, Wang Zhiyuan, Qian Bing, Nie Xiaoyan, Guan Xiaodong, Shi Luwen, Jing Chen, 2021
  • Research on the Necessity and Feasibility of Legislation for Children's Medication in China, Jing Chen, Wei Guoxu, Bai Lin, Wang Xiaoling, Shi Luwen, 2020
  • Research on Solving the Accessibility of AIDS Drugs under the Framework of Intellectual Property Protection, Jing Chen, Nie Xiaoyan, Bai Lin, Shi Luwen, 2020
  • Impact of the Pilot City Volume-Based Procurement Policy on the Utilization of Original and Generic Cardiovascular Drugs in Outpatient Departments of a Tertiary General Hospital, Wang Hui, Li Xin, Jing Chen, 2020
Pharmaceutical Policy Pharmaceutical Law Drug Regulation Intellectual Property Drug Safety Health Policy Clinical Pharmacy Pharmaceutical Management Drug Approval Generic Drugs

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.